J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paterson, G K
Right arrow Articles by Mitchell, T J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paterson, G K
Right arrow Articles by Mitchell, T J
Agricola
Right arrow Articles by Paterson, G K
Right arrow Articles by Mitchell, T J
J Med Microbiol 54 (2005), 323-326; DOI: 10.1099/jmm.0.45873-0
© 2005 Society for General Microbiology
ISSN 0022-2615

Role of interleukin-18 in experimental infections with Streptococcus pneumoniae

G K Paterson, C E Blue{dagger} and T J Mitchell

Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK

Correspondence T. J. Mitchell t.mitchell{at}bio.gla.ac.uk

Received August 20, 2004
Accepted December 16, 2004

IL-18, a multifunctional cytokine, has been shown to be involved in the immune response to numerous pathogens including several bacterial species. To study its role in infection by the Gram-positive bacterium Streptococcus pneumoniae, wild-type and IL-18 knockout BALB/c mice were compared in murine models of pneumococcal pneumonia, bacteraemia and nasopharyngeal colonization. The influence of IL-18 varied with the infection type, whereby it contributed to increased bacterial loads in pneumonia, reduced levels of colonization and had no effect on levels of bacteraemia following intravenous challenge. Likewise, the influence of IL-18 on pneumonia varied between two infecting pneumococcal strains. Comparison of these results with previous data also suggested that the influence of IL-18 in pneumococcal pneumonia differs with the mouse strain genetic background. Overall, these results demonstrate the complex influence of IL-18 in the response to the pneumococcus.

{dagger}Present address: Division of Virology, University of Glasgow, Glasgow G11 5JR, UK.

Abbreviations: BALF, bronchoalveloar lavage fluid; IFN, interferon; IL, interleukin.


   INTRODUCTION
TOP
 INTRODUCTION
METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
The Gram-positive bacterium Streptococcus pneumoniae (the pneumococcus) is an important human pathogen worldwide. The most common pneumococcal diseases are pneumonia, bacteraemia, meningitis and otitis media. In the USA alone, the pneumococcus is estimated to cause 7 000 000 cases of otitis media, 500 000 cases of pneumonia, 50 000 cases of bacteraemia and 3000 cases of meningitis per year (Obaro, 2000). Additionally, in developing countries, pneumococcal pneumonia is estimated to cause 1 000 000 deaths in children under the age of five (Denny & Loda, 1986). Drawbacks with the current vaccines and the spread of antibiotic resistance pose important difficulties in the prevention and treatment of infection. It is in this setting that continued efforts are made to understand host–pathogen interactions with the ultimate aim of improving therapy.

Several cytokines have been shown to have important functions in host defence against Streptococcus pneumoniae. Among them, IL-18, a pleiotropic cytokine, has been demonstrated to have a key role in infections caused by several bacterial pathogens including group B streptococci (Cusumano et al., 2004), Staphylococcus aureus (Wei et al., 1999), Shigella flexneri (Sansonetti et al., 2000), Yersinia enterocolitica (Bohn et al., 1998), Escherichia coli (Weijer et al., 2003), Salmonella typhimurium (Mastroeni et al., 1999), Pseudomonas aeruginosa (Huang et al., 2002; Schultz et al., 2003) and Legionella pneumophila (Brieland et al., 2000). In the case of Streptococcus pneumoniae, it has been shown that IL-18 is protective in a pneumonia model (Lauw et al., 2002) but detrimental in a meningitis model (Zwijnenburg et al., 2003).

To explore further the influence of IL-18 in pneumococcal infections, we compared the response to infection of wild-type and IL-18 knockout mice. Our data demonstrated that the influence of IL-18 in pneumococcal–host interactions is dependent on the bacterial strain, type of infection and host genetic background. IL-18 therefore has a complex influence in pneumococcal infections.


   METHODS
TOP
 INTRODUCTION
 METHODS
RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Mice.

Mice were housed at the Central Research Facility, University of Glasgow, UK, and all work was carried out with appropriate licensing and approval from the Home Office and University of Glasgow. IL-18 –/– mice were generated as described previously (Wei et al., 1999) and backcrossed on to a BALB/c background over eight generations. Sex- and age-matched (8–13-week-old) homozygous IL-18 –/– and wild-type mice were used in all experiments. Male and female mice gave similar results in the parameters measured. Breeding stock genotypes were confirmed by PCR of genomic DNA as previously described (Jiang et al., 2001). Female MF-1 mice (8–12 weeks old) used for mouse passage of bacterial strains were purchased from Harlan Olac, Bicester, UK.

Bacteria.

Strains used were Streptococcus pneumoniae strain D39, serotype 2 (NCTC 7466; Central Public Health Laboratory, London, UK) and the serotype 3 strain ATCC 6303. Bacteria were grown on blood agar base number 2 (Oxoid) with 5 % (v/v) defibrinated horse blood (E&O Laboratories) or in brain heart infusion (Oxoid). All incubations were static at 37 °C.

Infection of mice.

Prior to use in mice, strains were passaged by intraperitoneal injection in MF-1 mice to maintain virulence as described previously (Alexander et al., 1994), unless otherwise stated. Aliquots of bacteria were stored at –80 °C. When required, aliquots were thawed rapidly, harvested by centrifugation and resuspended in sterile PBS to the required concentration (see doses below). For intranasal infection to induce pneumonia, mice were lightly anaesthetized with halothane (Zeneca Pharmaceuticals) over oxygen using a calibrated vaporizer and 50 µl bacterial suspension (containing the dose indicated) was administered to the nares. Viable counts of the bacterial suspension were determined immediately before and after the challenge to confirm the dose. For intravenous infection, 50 µl bacterial suspension containing 105 c.f.u. was injected into the lateral tail vein. A blood count was taken 1 min after the injection from a separate vein to confirm that the infection was successful. For the colonization model, mice were challenged intranasally with 106 c.f.u. in a 10 µl volume resulting in nasopharyngeal carriage without pneumonia (Kerr et al., 2004).

Bacteriology.

In the pneumonia model, mice were sacrificed by cervical dislocation and bacterial viable counts taken from bronchoalveloar lavage fluid (BALF) and lung tissues. For bronchoalveloar lavage, tubing was inserted into the trachea and the lungs lavaged with 2x1 ml PBS. Lungs were then collected into 5 ml PBS and homogenized with an electrical tissue homogenizer (IKA UltraTurrax T25; Janke and Kunkel). Serial 10-fold dilutions of both lavage fluid and homogenized lung tissue were plated out and viable counts determined. Counts were pooled to give the total lung count. Following intravenous challenge, mice were tail bled at pre-determined time points and viable counts determined. For the colonization model, mice were sacrificed by cervical dislocation and bacterial viable counts taken from nasal washings with 2 ml PBS.

Cytokine analysis.

Aliquots of BALF were snap frozen in liquid nitrogen and stored at –80 °C until analysis for cytokines. Interferon (IFN)-{gamma} was measured by ELISA using paired antibodies from Pharmingen (catalogue nos 554431 and 554410; detection limit ~15 pg ml–1).

Statistics.

Bacterial counts and IFN-{gamma} levels were compared by Mann–Whitney U test analysis, where P < 0.05 was considered significant.


   RESULTS
TOP
 INTRODUCTION
 METHODS
 RESULTS
DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 
Influence of IL-18 on pneumococcal pneumonia

To assess the role of IL-18 in pneumococcal pneumonia, bacterial loads in the lungs of wild-type and IL-18 knockout BALB/c mice were compared after intranasal challenge with 106 c.f.u. serotype 2 strain D39. At 24 h, IL-18 knockout mice showed enhanced clearance of bacteria compared with their wild-type counterparts (Fig. 1a). This difference was transient, as bacterial counts in the lung were similar in the two mouse strains at 12 and 48 h post-infection (Fig. 1a). In this model, therefore, IL-18 appeared to reduce bacterial clearance slightly at 24 h. A major activity of IL-18 is the induction of IFN-{gamma}. As previous work has demonstrated a detrimental role for IFN-{gamma} in murine pneumococcal pneumonia, we compared the levels of this cytokine in BALF between wild-type and IL-18 knockout mice (Rijneveld et al., 2002). At 24 h post-infection, there was a significant reduction in IFN-{gamma} levels in the IL-18 knockout mice compared with wild-type (mean ± SEM for wild-type mice of 259 ± 45 pg ml–1 compared with 116 ± 8 pg ml–1 for knockout mice, P < 0.05).



View larger version (20K):
[in this window]
[in a new window]
  		Fig. 1. Bacterial counts in the lung following intranasal infection with 106 c.f.u. D39 (a) or ATCC 6303 (b) in wild-type (filled columns) and IL-18 knockout (open columns) BALB/c mice (n = 5–13 for D39, n = 6 for ATCC 6303). Data are means ± SE. *P < 0.05 compared with wild-type mice.

 

A bacterial-strain-dependent role for IL-18 in pneumococcal pneumonia

To determine whether the influence of IL-18 on pneumococcal pneumonia shown for D39 was specific to the strain used, we repeated the infection using the serotype 3 strain ATCC 6303. At the time points examined, no significant difference was seen between the two mouse strains (Fig. 1b). This demonstrated that the effect of IL-18 on pneumococcal pneumonia was influenced by the bacterial strain used. When BALF IFN-{gamma} was measured, there was no significant difference between the two strains, although there was a strong trend for higher levels in the wild-type mice (data not shown).

Role of IL-18 in other pneumococcus–host interactions

To examine the role of IL-18 in other pneumococcal infection types, BALB/c wild-type and IL-18 knockout mice were compared following intravenous infection to represent bacteraemia and in a nasopharyngeal colonization model. Following intravenous infection, no difference was seen in blood bacterial counts between the two mouse strains at the time points examined (6, 12 and 24 h; data not shown). During nasopharyngeal colonization, IL-18 knockout mice showed diminished clearance of D39 at day 7 (Fig. 2). This effect was transient as counts at day 3 and 10 were not significantly different between the strains, although at day 10 IL-18 knockout mice showed a trend towards higher counts. IFN-{gamma} levels were below the detection limit of 15 pg ml–1 in the nasopharyngeal washings.



View larger version (12K):
[in this window]
[in a new window]
  		Fig. 2. Nasopharyngeal bacterial counts following colonization of wild-type (filled columns) and IL-18 knockout (open columns) BALB/c mice (n = 6–12) with D39. Data are means ± SE. *P < 0.05 compared with wild-type mice.

 

In these models, therefore, IL-18 did not appear to play a significant role in bacteraemia infection, but contributed towards controlling levels of colonization in the nasopharynx. The influence of IL-18 in pneumococcal infection is therefore complex and varies with the infection model.

Mouse strain influence on the role of IL-18 in pneumococcal pneumonia

Data from our pneumonia infections with the strains D39 and ATCC 6303 are in disagreement with the work of Lauw et al. (2002). Using strain ATCC 6303, they demonstrated a protective influence of IL-18 in pneumococcal pneumonia, whereby IL-18 knockout mice showed enhanced bacterial counts in the lung compared with wild-type mice. In addition to employing a different mouse strain (C57/Bl6) to us, their work also administered a smaller dose (105 c.f.u.) and used bacteria that were not first mouse passaged. To resolve the discrepancy between these results, we repeated our pneumonia infection using unpassaged ATCC 6303 at 105 c.f.u. per mouse. When lung bacterial counts were compared between mouse strains at 48 h post-infection, no difference was evident (data not shown). Forty-eight hours was chosen because Lauw et al. (2002) showed the greatest difference in bacterial counts between the mouse strains at this time point.


   DISCUSSION
TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
ACKNOWLEDGEMENTS
 REFERENCES
 
To investigate the role of IL-18 in pneumococcal pneumonia, we compared bacterial lung counts between wild-type and IL-18 knockout BALB/c mice following infection with 106 c.f.u. serotype 2 strain D39. BALB/c mice in this infection model are a comparatively resistant strain and have been studied in attempts to understand genetic resistance to the pneumococcus (Gingles et al., 2001; Kerr et al., 2002). Our data suggested that IL-18 does not contribute to the inherent resistance of BALB/c mice in this model. Indeed, IL-18 in this model was responsible for a transient decrease in bacterial clearance and may therefore be classed as detrimental. The phenotype appears only minor, as bacterial counts were the same in both genotypes later in infection. BALB/c mice are also relatively resistant to intravenous infection with D39 (Kerr et al., 2002). Our data demonstrated that IL-18 is not essential for this resistance. The resistance of BALB/c mice to D39 intranasal and intravenous infection correlates with abundant and early production of TNF-{alpha} after infection (Kerr et al., 2002). The dominant influence of this cytokine in BALB/c mice following pneumococcal infection may explain the relatively minor phenotype seen in IL-18 knockout mice.

The decreased clearance of D39 in the wild-type mice during pneumonia correlated with increased IFN-{gamma} production compared with IL-18 knockout mice. This cytokine has been shown previously to be detrimental in a model of pneumococcal pneumonia (Rijneveld et al., 2002) and the higher levels seen here in wild-type mice may have contributed to the reduced bacterial clearance relative to the IL-18 knockout mice.

When the pneumonia infection was repeated using the serotype 3 strain ATCC 6303, no difference in lung bacterial counts was seen between the two mouse strains. This demonstrated that the influence of IL-18 in pneumococcal pneumonia is determined by the infecting bacterial strain. The reason is unclear, but it has been documented that different pneumococcal strains can induce different cytokine responses and this may be a contributing factor whereby one strain may induce higher or lower levels of beneficial or detrimental cytokines (Mohler et al., 2003).

We also demonstrated that the role of IL-18 in pneumococcal infection varies with different types of infection. Whereas in pneumonia it impaired bacterial clearance, the opposite was seen in a model of nasopharyngeal colonization, while, in contrast, no effect was seen in a bacteraemia model. This expands previous data showing a protective role in pneumococcal pneumonia (Lauw et al., 2002) but a detrimental one in a meningitis model (Zwijnenburg et al., 2003). Similarly, IL-18 is protective in a mouse model of P. aeruginosa keratitis (Huang et al., 2002) but impaired bacterial clearance in a pneumonia model with the same organism (Schultz et al., 2003). Furthermore, IL-18 administration had opposing effects on E. coli infections in burn-injured mice depending on the severity of the burns (Kinoshita et al., 2004).

In addition to the influence of bacterial strain and infection type on the role of IL-18 in pneumococcal infection, it appears that host genetic background is also important. Previously, Lauw et al. (2002) demonstrated that IL-18 knockout C57/Bl6 mice had increased bacterial lung counts compared with wild-type mice following pneumococcal pneumonia with strain ATCC 6303. When we repeated this infection using BALB/c mice, no difference was seen between the wild-type and IL-18 knockout mice with regard to bacterial lung counts. It therefore seems that IL-18 influences pneumococcal pneumonia differently depending on the host genetic background. A similar effect has been described for the role of IL-18 in response to Leishmania major infection in mice (Wei et al., 2004).

Taken together, we have demonstrated that IL-18 exerts differing effects on pneumococcal infection depending on the infecting bacterial strain, the infection type and the host genetic background. These data exemplify the complexity of IL-18 in the immune response to Streptococcus pneumoniae.


   ACKNOWLEDGEMENTS
TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
REFERENCES
 
We thank Professor F. Y. Liew, University of Glasgow, UK, for the kind gift of BALB/c wild-type and IL-18 knockout breeding pairs. The animal husbandry of the Central Research Facility staff is also gratefully acknowledged. This work was supported by a Wellcome Trust 4-Year PhD Studentship to G. K. P.


   REFERENCES
TOP
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGEMENTS
 REFERENCES
 

  • Alexander, J. E., Lock, R. A., Peeters, C. C., Poolman, J. T., Andrew, P. W., Mitchell, T. J., Hansman, D. & Paton, J. C. (1994). Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 62, 5683–5688.[Abstract/Free Full Text]

  • Bohn, E., Sing, A., Zumbihl, R., Bielfeldt, C., Okamura, H., Kurimoto, M., Heeseman, J. & Autenrieth, I. (1998). IL-18 (IFN-{gamma}-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 160, 299–307.[Abstract/Free Full Text]

  • Brieland, J. K., Jackson, C., Hurst, S. & 8 other authors (2000). Immunomodulatory role of endogenous interleukin-18 in gamma interferon-mediated resolution of replicative Legionella pneumophila lung infection. Infect Immun 68, 6567–6573.[Abstract/Free Full Text]

  • Cusumano, V., Midiri, A., Cusumano, V. V., Bellantoni, A., de Sossi, G., Teti, G., Beninati, C. & Mancuso, G. (2004). Interleukin-18 is an essential element in host resistance to experimental group B streptococcal disease in neonates. Infect Immun 72, 295–300.[Abstract/Free Full Text]

  • Denny, F. W. & Loda, F. A. (1986). Acute respiratory infections are the leading cause of death in children in developing countries. Am J Trop Med Hyg 35, 1–2.

  • Gingles, N. A., Alexander, J. E., Kadioglu, A. & 10 other authors (2001). Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect Immun 69, 426–434.[Abstract/Free Full Text]

  • Huang, X., McClellan, S. A., Barrett, R. P. & Hazlett, L. D. (2002). IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-{gamma} production. J Immunol 168, 5756–5763.[Abstract/Free Full Text]

  • Jiang, H.-R., Wei, X.-Q., Niedbala, W., Lumsden, L., Liew, F. Y. & Forrester, J. V. (2001). IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest Ophthalmol Vis Sci 42, 177–182.[Abstract/Free Full Text]

  • Kerr, A. R., Irvine, J. J., Search, J. J., Gingles, N. A., Kadioglu, A., Andrew, P. W., McPheat, W. L., Booth, C. G. & Mitchell, T. J. (2002). Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect Immun 70, 1547–1557.[Abstract/Free Full Text]

  • Kerr, A. R., Adrian, P. V., Estevao, S., de Groot, R., Alloing, G., Claverys, J. P., Mitchell, T. J. & Hermans, P. W. (2004). The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect Immun 72, 3902–3906.[Abstract/Free Full Text]

  • Kinoshita, M., Seki, S., Ono, S., Shinomiya, N. & Hiraide, H. (2004). Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice. Ann Surg 240, 313–320.[CrossRef][Medline]

  • Lauw, F. N., Branger, J., Florquin, S., Speelman, P., van Deventer, S. J., Akira, S. & van der Poll, T. (2002). IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J Immunol 168, 372–378.[Abstract/Free Full Text]

  • Mastroeni, P., Clare, S., Khan, S., Harrison, J. A., Hormaeche, C. E., Okamura, H., Kurimoto, M. & Dougan, G. (1999). Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 67, 478–483.[Abstract/Free Full Text]

  • Mohler, J., Azoulay-Dupuis, E., Amory-Rivier, C., Mazoit, J. X., Bedos, J. P., Rieux, V. & Moine, P. (2003). Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia. Intensive Care Med 29, 808–816.[Medline]

  • Obaro, S. K. (2000). Confronting the pneumococcus: a target shift or bullet change? Vaccine 19, 1211–1217.[CrossRef][Medline]

  • Rijneveld, A. W., Lauw, F. N., Schultz, M. J., Florquin, S., te Velde, A. A., Speelman, P., van Deventer, S. J. & van der Poll, T. (2002). The role of interferon-{gamma} in murine pneumococcal pneumonia. J Infect Dis 185, 91–97.[CrossRef][Medline]

  • Sansonetti, P. J., Phalipon, A., Arondel, J., Thirumalai, K., Banerjee, S., Akira, S., Takeda, K. & Zychlinsky, A. (2000). Caspase-1 activation of IL-1ß and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 12, 581–590.[CrossRef][Medline]

  • Schultz, M. J., Knapp, S., Florquin, S., Pater, J., Takeda, K., Akira, S. & van der Poll, T. (2003). Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect Immun 71, 1630–1634.[Abstract/Free Full Text]

  • Wei, X.-Q., Leung, B. P., Niedbale, W., Piedraftita, D., Feng, G.-J., Sweet, M., Dobbie, L., Smith, A. J. H. & Liew, F. Y. (1999). Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J Immunol 163, 2821–2828.[Abstract/Free Full Text]

  • Wei, X.-Q., Niedbala, W., Xu, D., Luo, Z.-X., Pollock, K. G. & Brewer, J. M. (2004). Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol Lett 94, 35–37.[CrossRef][Medline]

  • Weijer, S., Sewnath, M. E., de Vos, A. F., Florquin, S., van der Sluis, K., Gouma, D. J., Takeda, K., Akira, S. & van der Poll, T. (2003). Interleukin-18 facilitates the early antimicrobial host response to Escherichia coli peritonitis. Infect Immun 71, 5488–5497.[Abstract/Free Full Text]

  • Zwijnenburg, P. J., van der Poll, T., Florquin, S. & 8 other authors (2003). Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis. J Neuroimmunol 138, 31–37.[CrossRef][Medline]




    This article has been cited by other articles:


    		Home page
    		 Infect. Immun.Home page
    S. Shoma, K. Tsuchiya, I. Kawamura, T. Nomura, H. Hara, R. Uchiyama, S. Daim, and M. Mitsuyama
    Critical Involvement of Pneumolysin in Production of Interleukin-1{alpha} and Caspase-1-Dependent Cytokines in Infection with Streptococcus pneumoniae In Vitro: a Novel Function of Pneumolysin in Caspase-1 Activation
    Infect. Immun., April 1, 2008; 76(4): 1547 - 1557.
    [Abstract] [Full Text] [PDF]

    		Home page
    		 Am. J. Pathol.Home page
    S. L. Farnworth, N. C. Henderson, A. C. MacKinnon, K. M. Atkinson, T. Wilkinson, K. Dhaliwal, K. Hayashi, A. J. Simpson, A. G. Rossi, C. Haslett, et al.
    Galectin-3 Reduces the Severity of Pneumococcal Pneumonia by Augmenting Neutrophil Function
    Am. J. Pathol., February 1, 2008; 172(2): 395 - 405.
    [Abstract] [Full Text] [PDF]

    		Home page
    		 Infect. Immun.Home page
    A. M. C. van Rossum, E. S. Lysenko, and J. N. Weiser
    Host and Bacterial Factors Contributing to the Clearance of Colonization by Streptococcus pneumoniae in a Murine Model
    Infect. Immun., November 1, 2005; 73(11): 7718 - 7726.
    [Abstract] [Full Text] [PDF]

    This Article
    Right arrow Abstract Freely available
    Right arrow Full Text (PDF)
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Right arrow Citation Map
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Download to citation manager
    Right arrow reprints & permissions
    Citing Articles
    Right arrow Citing Articles via HighWire
    Right arrow Citing Articles via CrossRef
    Right arrow Citing Articles via Google Scholar
    Google Scholar
    Right arrow Articles by Paterson, G K
    Right arrow Articles by Mitchell, T J
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Paterson, G K
    Right arrow Articles by Mitchell, T J
    Agricola
    Right arrow Articles by Paterson, G K
    Right arrow Articles by Mitchell, T J

    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
    INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS